Differential outcome of concurrent radiotherapy plus epidermal growth factor receptor inhibitors versus radiotherapy plus cisplatin in patients with human papillomavirus-related head and neck cancer.

Serum levels of vascular endothelial growth factor-A 165 , soluble vascular endothelial growth factor receptor 1, and hepatocyte growth factor were assessed by

Morphofunctional and Molecular Assessment of Nutritional Status in Head and Neck Cancer Patients Undergoing Systemic Treatment: Role of Inflammasome in Clinical Nutrition..

(2015) Human Epidermal Growth Factor Receptor 2 (HER2)–specific chimeric antigen receptor–modified T cells for the Immunotherapy of HER2- positive sarcoma.. Journal of

Vali- dation of the risk model: high-risk classification and tumor pattern of invasion predict outcome for patients with low-stage oral cavity squamous cell carcinoma. Head

Background: AURA study reported 61% objective response rate and progression-free survival of 9.6 months with osimertinib in patients with EGFR/T790M+ non-small cell lung cancer.. Due

Anti-epidermal growth factor receptor therapy in combination with chemoradiotherapy for the treatment of locally advanced anal canal carcinoma: results of a phase I

Growth regulation of human colon cancer cells by epidermal growth factor and 1,25-dihydroxyvitamin D 3 is mediated by mutual modulation of receptor expression. The down-regulation

Nguyen PL, Swanson PE, Jaszcz W, et al (1994) Expression of epidermal growth factor receptor in invasive transitional cell carcinoma of the urinary bladder: a multivariate